14-67887196-T-G
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2
The NM_133510.4(RAD51B):āc.748T>Gā(p.Ser250Ala) variant causes a missense change. The variant allele was found at a frequency of 0.00156 in 1,606,150 control chromosomes in the GnomAD database, including 35 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
NM_133510.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RAD51B | NM_133510.4 | c.748T>G | p.Ser250Ala | missense_variant | 7/11 | ENST00000471583.6 | NP_598194.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RAD51B | ENST00000471583.6 | c.748T>G | p.Ser250Ala | missense_variant | 7/11 | 1 | NM_133510.4 | ENSP00000418859.1 |
Frequencies
GnomAD3 genomes AF: 0.00835 AC: 1270AN: 152182Hom.: 13 Cov.: 32
GnomAD3 exomes AF: 0.00216 AC: 531AN: 245786Hom.: 10 AF XY: 0.00169 AC XY: 224AN XY: 132592
GnomAD4 exome AF: 0.000841 AC: 1223AN: 1453850Hom.: 21 Cov.: 30 AF XY: 0.000780 AC XY: 564AN XY: 722954
GnomAD4 genome AF: 0.00838 AC: 1277AN: 152300Hom.: 14 Cov.: 32 AF XY: 0.00808 AC XY: 602AN XY: 74480
ClinVar
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 08, 2024 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Hereditary breast ovarian cancer syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | National Health Laboratory Service, Universitas Academic Hospital and University of the Free State | Apr 19, 2022 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at